Clinical Trial Update: Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Triamcinolone Acetonide in combination with laser therapy for age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Degeneration | Phase 3 | Status: COMPLETED